While further research is warranted to validate these findings across diverse populations and refine diagnostic criteria, the evidence presented by Rani et al. supports the promising role of salivary IL-6 as a valuable biomarker for oral cancer detection and management [10]. This evidence concerns the gene IL6 and lip and oral cavity carcinoma.